Suppr超能文献

2007年1月至2008年8月12日尼日利亚在根除脊髓灰质炎方面取得的进展

Progress toward poliomyelitis eradication--Nigeria, January 2007-August 12, 2008.

出版信息

MMWR Morb Mortal Wkly Rep. 2008 Aug 29;57(34):942-6.

Abstract

Nigeria is one of only four countries that have never interrupted poliovirus transmission (the others are Afghanistan, India, and Pakistan). A resurgence in wild poliovirus (WPV) transmission occurred in Nigeria during 2003-2004 after a loss of public confidence in oral poliovirus vaccine (OPV) and suspension of supplementary immunization activities (SIAs)* in several northern states. Subsequently, WPV spread within Nigeria and ultimately into 20 previously polio-free countries during 2003-2006. Even after national SIAs resumed, limited acceptance and ongoing operational problems resulted in low polio vaccination coverage and continued WPV transmission. Beginning in 2006, health authorities in Nigeria introduced new initiatives to control the spread of WPV, including a focus on interrupting type 1 WPV (WPV1) transmission and use of monovalent type 1 OPV (mOPV1) for most of the SIAs to increase vaccine effectiveness. Nigeria also instituted changes in SIA implementation to increase community acceptance of vaccination. Subsequently, 285 polio cases were reported in Nigeria in 2007, the lowest number since sensitive surveillance has been in place. As of August 12, 2008, confirmed polio cases reported in Nigeria totaled 556 (including 511 WPV1 cases), compared with 176 cases (53 WPV1) reported during the same period in 2007. This report updates overall progress toward polio eradication in Nigeria during 2007-2008. Given the increase in WPV transmission thus far in 2008, urgent measures are needed to reach all children during SIAs to bring WPV under control in Nigeria.

摘要

尼日利亚是仅有的四个从未中断脊髓灰质炎病毒传播的国家之一(其他三个国家是阿富汗、印度和巴基斯坦)。2003 - 2004年期间,由于公众对口服脊髓灰质炎疫苗(OPV)失去信心以及尼日利亚北部几个州暂停了补充免疫活动(SIAs)*,野生脊髓灰质炎病毒(WPV)传播出现反弹。随后,WPV在尼日利亚境内传播,并最终在2003 - 2006年期间传播到20个以前无脊髓灰质炎的国家。即使在全国性补充免疫活动恢复之后,由于接受程度有限以及持续存在的操作问题,脊髓灰质炎疫苗接种覆盖率仍然很低,WPV传播持续。从2006年开始,尼日利亚卫生当局推出了控制WPV传播的新举措,包括着重阻断1型WPV(WPV1)传播,并在大多数补充免疫活动中使用单价1型OPV(mOPV1)以提高疫苗效力。尼日利亚还对补充免疫活动的实施方式进行了变革,以提高社区对接种疫苗的接受度。随后,2007年尼日利亚报告了285例脊髓灰质炎病例,这是开展敏感监测以来的最低数字。截至2008年8月12日,尼日利亚报告的确诊脊髓灰质炎病例总数为556例(包括511例WPV1病例),而2007年同期报告的病例数为176例(53例WPV1)。本报告更新了2007 -

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验